It gave good results in a trial for advanced melanoma when used in combination with interleukin-2. Another trial against Ipilimumab in advanced melanoma suggested Ipilimumab may be better than the<unk>  vaccine alone.
Gp100:209-217
SRD5A3-CDG
P1-185
COVAX-19
AP-7 
BGR-34
ALG1-CDG
ALD-52